NAACCR Item #3857: High Risk Cytogenetics

Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired
3,857 1 NAACCR 2018 18

NAACCR XML: Tumor.highRiskCytogenetics


High Risk Cytogenetics is defined as one or more of t(4;14), t(14;16), or del 17p identified from FISH test results and is part of the staging criteria for plasma cell myeloma.


High Risk Cytogenetics is a prognostic factor required in AJCC 8th edition, Chapter 82 Plasma Cell Myeloma and Plasma Cell Disorders, for staging of plasma cell myeloma.


0High-risk cytogenetics not identified/not present
1High-risk cytogenetics present
5Schema Discriminator 1: Plasma Cell Myeloma Terminology coded to 1 or 9
7Test ordered, results not in chart
9Not documented in medical record High Risk Cytogenetics not assessed or unknown if assessed

Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.